Ex-Chelsea hothead Diego Costa ‘having medical’ at Wolves in surprise transfer

Wolves are plotting a shock swoop for former Chelsea star Diego Costa, who is available on a free transfer.

Bruno Lage has had striker troubles this season through form and fitness with Raul Jimenez out injured. After splashing out on Manchester United target Sasa Kalajdzic, it looked like their problems had been solved.

But less than 45 minutes into his debut against Southampton, the Austria international suffered an ACL injury and could miss the entire season in a devastating blow to Wolves and the player.

READ MORE: Hooters banned from sponsoring under-10s football team after sending waitresses

And according to The Athletic, the Molineux outfit has turned to Costa as a potential solution and are looking to sign him up as quickly as possible, scheduling a medical for Tuesday.

The 33-year-old had his contract terminated at Brazilian club Atletico Mineiro and has been a free agent since January. Wolves had been linked with the striker prior to the return to his home country.

But if a deal is agreed, it would be the return of a striker that was full of controversy during his time at Chelsea. His snarling attitude and aggression made him a cult hero at Stamford Bridge but the pantomime villain to many others.

However, his antics in front of goal were crucial for the Blues where he scored 52 times in 89 Premier League appearances. Costa's time in west London ended as expected – a whirlwind of controversy – when then-manager Antonio Conte told him by text he was not needed.

If Costa does sign for Wolves, all eyes will be on his return to Stamford Bridge where he is still revered by Chelsea fans. That will go ahead on 8 October and could be one to bring the popcorn to.


  • Ronaldo hoped to become 'the new Hugh Hefner' and buy entire Playboy franchise

  • Ibiza's football club completes transfer for Coke – and fans all make the same joke

  • Shameful footballers ‘beat up’ referee after red card and threw him into a ravine

Source: Read Full Article